Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.astecls.com | |
Market Cap | 2,710.38 Cr. | |
Enterprise Value(EV) | 2,956.44 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 37.54 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 36.48 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 20.01 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 216.48 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 6.33 | Calculated using Price: 1,369.40 |
Dividend Yield | 0.11 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.96 Cr. | 19,605,660 Shares |
FaceValue | 10 | |
Company Profile | ||
Astec is proud of its rich experience of over two decades in the chemical industry. The company employs highly qualified and trained personnel to monitor and maintain its manufacturing activities as well as process development work. Astec prides itself in being responsive, reliable and quick to implement projects. A strong R&D focus has enabled the company to introduce a number of unique products. As the operations are highly integrated both vertically and horizontally, Astec has a very efficient, low cost structure in the market place. |
1 Day |
|
+5.70% |
1 Week |
|
+13.35% |
1 Month |
|
+1.47% |
3 Month |
|
-22.01% |
6 Month |
|
-26.11% |
1 Year |
|
-21.86% |
2 Year |
|
+36.90% |
5 Year |
|
+135.41% |
10 Year |
|
+8002.96% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 7.91 | 11.88 | 4.01 | 15.07 | 22.90 | 19.31 | 21.24 | 23.46 | 25.50 | |
Return on Capital Employed (%) | 10.88 | 11.96 | 10.65 | 16.08 | 23.75 | 20.31 | 20.44 | 22.29 | 22.21 | |
Return on Assets (%) | 3.17 | 4.57 | 1.47 | 5.80 | 9.38 | 8.18 | 9.20 | 10.42 | 11.42 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 113 | 135 | 118 | 138 | 170 | 202 | 247 | 309 | 397 | 424 | |
Non Curr. Liab. | 54 | 49 | 6 | 2 | 5 | 9 | 6 | 46 | 10 | 48 | |
Curr. Liab. | 117 | 178 | 203 | 194 | 238 | 249 | 318 | 322 | 491 | 482 | |
Minority Int. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Equity & Liab. | 284 | 362 | 328 | 334 | 413 | 461 | 572 | 678 | 897 | 954 | |
Non Curr. Assets | 150 | 158 | 136 | 135 | 182 | 213 | 240 | 347 | 381 | 408 | |
Curr. Assets | 135 | 204 | 191 | 198 | 232 | 248 | 332 | 330 | 516 | 546 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 284 | 362 | 328 | 334 | 413 | 461 | 572 | 678 | 897 | 954 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 207 | 267 | 247 | 299 | 368 | 431 | 523 | 555 | 677 | 773 | |
Other Income | 0 | 1 | 7 | 3 | 8 | 11 | 12 | 8 | 11 | 17 | |
Total Income | 207 | 268 | 254 | 302 | 376 | 442 | 535 | 563 | 687 | 790 | |
Total Expenditure | -172 | -213 | -215 | -236 | -299 | -354 | -437 | -443 | -523 | -637 | |
PBIDT | 36 | 55 | 39 | 65 | 77 | 88 | 97 | 119 | 165 | 154 | |
Interest | -9 | -13 | -13 | -12 | -11 | -12 | -13 | -5 | -9 | -18 | |
Depreciation | -15 | -13 | -10 | -14 | -15 | -19 | -23 | -26 | -34 | -37 | |
Taxation | -3 | 2 | -7 | -10 | -21 | -20 | -14 | -24 | -31 | -26 | |
Exceptional Items | -1 | -17 | -3 | -11 | 4 | ||||||
PAT | 9 | 15 | 5 | 19 | 35 | 36 | 48 | 65 | 90 | 74 | |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 9 | 15 | 5 | 19 | 35 | 36 | 48 | 65 | 90 | 74 | |
Adjusted EPS | 5 | 8 | 3 | 10 | 18 | 18 | 24 | 33 | 46 | 38 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 16 | 15 | 7 | -13 | 19 | 65 | 15 | 168 | -8 | 24 | |
Cash Fr. Inv. | -13 | -19 | -19 | -16 | -18 | -49 | -53 | -74 | -73 | -104 | |
Cash Fr. Finan. | -2 | 3 | 12 | 31 | -1 | -18 | 37 | -95 | 81 | 80 | |
Net Change | 1 | -1 | 0 | 2 | 1 | -3 | 0 | 0 | 0 | 0 | |
Cash & Cash Eqvt | 5 | 4 | 1 | 2 | 3 | 0 | 0 | 0 | 0 | 1 |
Fri, 31 Mar 2023
Clarification sought from Astec Lifesciences Ltd The Exchange has sought clarification from Astec Lifesciences Ltd on March 31 2023 with reference to Movement in Volume. The reply is awaited. |
Fri, 31 Mar 2023
Reply On Significant Increase In The Volume Of Security Across Exchanges In The Recent Past Vide Your E-Mail Notice Ref. No.: L/SURV/ONL/PV/MG/ 2022-2023 / 476 Dated 31St March 2023. Please find attached our reply on significant increase in the volume of security across Exchanges in the recent past vide your E-mail Notice bearing Ref. No.: L/SURV/ONL/PV/MG/ 2022-2023 / 476 dated 31st March 2023. |
Tue, 28 Mar 2023
Closure of Trading Window This is to inform you that as per the Companys Code of Conduct for Prohibition of Insider Trading framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in the securities of the Company will be closed with effect from Saturday 1st April 2023 till 48 (forty-eight) hours after the declaration of the Audited Financial Results of the Company for the Quarter and Financial Year ending 31st March 2023. |
Fri, 31 Mar 2023 |
|
|
|
|
|